Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 🎙 "En un deporte en el que cada detalle tiene gran importancia, con esta colaboración pretendemos que nuestros ciclistas puedan contar con una mayor asistencia para optimizar el rendimiento, mejorando la recuperación con una garantía de máxima calidad" [Juanjo Oroz] 🎙 "Este acuerdo fortalece la posición de Reboots en el deporte de élite y el compromiso del Equipo Kern Pharma con la ...

    • Actualidad

      El Equipo Kern Pharma viaja a Alpes Isère con ambición. La...

    • Conecta

      Usamos cookies para asegurar que te damos la mejor...

  2. Hace 18 horas · While the global medical devices market size was valued at $512.29bn in 2022 and is projected to grow from $536.12bn in 2023 to $799.67bn by 2030, with a CAGR of 5.9% over the period, this article focuses specifically on the three of the most popular markets – the EU, the UK and the USA – highlighting some key considerations relating to ...

  3. Hace 4 días · About the company. Essex Bio-Technology Ltd is an investment holding company principally engaged in the manufacture and sales of biopharmaceutical products for the treatment and healing of...

  4. Hace 3 días · European Pharmaceutical Manufacturer magazine: Breaking pharmaceutical and pharma manufacturing news, opinion and analysis - Including the latest breakthroughs in pharma, drug delivery, formulation, R&D, packaging, finance & investment, logistics & distribution, manufacturing, and pharma supply chain

  5. Hace 1 día · Pharma 2024, opens new tab. April 16-18 · Barcelona. Event. Digital Health USA 2024, opens new tab. May 14-15 · San Diego. Talking Points. Latest Stories. Corporate Structure.

  6. Hace 3 días · Pharmaceutics is the scientific discipline concerned with the process of creating the dosage form (such as a pill for oral administration or a powder for intravenous injection) of a therapeutic...

  7. Hace 1 día · Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million. Transactions. NEW YORK, NY, May 28, 2024 - Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired an interest in Agios Pharmaceuticals’ royalty on Servier’s vorasidenib for $905 million in upfront cash contingent on U.S. Food ...